• Medifirst Solutions Handheld laser device borders on being revolutionary
• The industry for medical lasers is projected to be over $10 billion by 2020
• Medifirst Solutions stock should appreciate considerably in the near term

Medifirst Solutions (OTC Nasdaq: MFST) is engaged in developing medical devices. The Company produces a hand-held mobile laser system known as The Time Machine Series Lasers (TML).

On July 8th, 2016, MFST subsidiary Medical Lasers Manufacturers, Inc. 510(k) application to market the TML was approved by the FDA (FDA clearance). Per information obtained from MFST website, the Time Machine Infrared Laser 810/830-nanometer, which operates in continuous wave mode set at a fixed frequency is intended for use in temporary relief of minor muscle and joint pain, stiffness, minor arthritis pain, muscle spasm, temporary increase in local blood circulation and temporary relaxation of muscles by means of topical elevated but non-painful tissue temperature from infrared spectral emissions.

Although the Infrared laser device was approved for pain relief, due to the decrease of inflammation, patients have also seen aesthetic improvements in scar healing from incisions and reduction of wrinkles. MFST has in its pipeline a TML Green light which will be presented in the coming months to the FDA for dermatological and cosmetic applications.

Based on the lack of response in the stock of MFST, it appears that the FDA approval has been completely overlooked by potential investors and given the small market cap of MFST, such an oversight is understandable. Now, I believe this product borders on being revolutionary. The efficacy of medical laser devices for pain management is well documented (see NIH). Now, the TML is not unique with respect efficacy, but what is unique is the fact that the hand-held stand-alone laser device, with pin-point accuracy, often gives patients immediate results with no redness, swelling or down-time. When compared to existing floor models which range in costs from $20,000.00 to $75,000.00. The TML device, per MFST marketing plan, will be sold for less than $10,000.00. It is a reasonable assumption that such a cost reduction to medical professionals would make the TML very attractive.

The market for the approved TML Infrared device are as follows:

• Hospitals, Surgical and Medical Centers
• Pain Specialists, Family Doctors, Chiropractic
• Dentists, Temporal Mandibular Joint syndrome (TMJ)…

Unlock the rest of this article with a 14 day trial

Unlock with Email
Unlock with Google

Already have an account?
Login here